The study of induction of ovulation with menotropins: Analysis of results of 1897 treatment cycles

G. Oelsner, D. M. Serr, S. Mashiach, J. Blankstein, M. Snyder, B. Lunenfeld

    Research output: Contribution to journalArticlepeer-review

    81 Scopus citations

    Abstract

    Menotropins are appropriate for patients lacking endogenous gonadotropins or for patients having ovaries capable of a normal response. This report is based upon computer tabulations of pooled data abstracted from 510 patients to whom 1897 treatment cycles with menotropins were administered during the last 15 years. The results of treatment are based upon detailed analyses in different groups of patients to whom the same gonadotropin preparation was administered according to a similar treatment schedule. The percentage of patients who conceived following therapy (the pregnancy rate) in group I (women with negligible endogenous estrogen activity and low gonadotropin levels) was 60.4%; in group II (women with normal gonadotropin levels and distinct endogenous estrogen activity in whom all other treatments had failed) the pregnancy rate was 21.4%. The success rates (the percentages of women who took home at least one living child) were 52.1% in group I and 14.5% in group II. Altogether, 250 children were born to 184 women who conceived following treatment. The mean numbers of treatment cycles per patient were 3.69 in group I and 3.24 in group II. Among women of group I who conceived, 94.1% did so within four treatment cycles and of group II patients 95.2% did so within six treatment cycles. The over-all mild hyperstimulation rate was 4.26% and the severe hyperstimulation rate was 0.36%. The over-all multiple pregnancy rate was 32.5%.

    Original languageEnglish
    Pages (from-to)538-544
    Number of pages7
    JournalUnknown Journal
    Volume30
    Issue number5
    DOIs
    StatePublished - 1978

    Bibliographical note

    Funding Information:
    Received May 15, 1978; accepted July 10, 1978. *Supported in part by Ford Foundation Grant 67-4 70 and by the World Health Organization. tReprint requests: Gabriel Oelsner, M.D., Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center Tel Hashomer, Tel Aviv University Medical School, Tel Hashomer, Israel. *Computer Center, Bar-llan University, Ramat Gan, Israel. §Institute of Endocrinology, The Chaim Sheba Medical Center Tal Hashomer, Bar-Ilan University, Ramat Gan, Israel.

    Fingerprint

    Dive into the research topics of 'The study of induction of ovulation with menotropins: Analysis of results of 1897 treatment cycles'. Together they form a unique fingerprint.

    Cite this